Bliss GVS Pharma Limited (BLISSGVS.BO)
INR 120.15
(3.0%)
INR 120.15
(3.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.18 Billion INR | 14.93% |
| 2022 | 1.03 Billion INR | -16.85% |
| 2021 | 1.23 Billion INR | 25.29% |
| 2020 | 989.27 Million INR | 33.44% |
| 2019 | 741.38 Million INR | -4.17% |
| 2018 | 773.67 Million INR | 31.06% |
| 2017 | 590.33 Million INR | 19.75% |
| 2016 | 492.98 Million INR | 27.48% |
| 2015 | 386.72 Million INR | 14.76% |
| 2014 | 337 Million INR | 3.6% |
| 2013 | 325.3 Million INR | 0.02% |
| 2012 | 325.23 Million INR | 156.47% |
| 2011 | 126.8 Million INR | 9.21% |
| 2010 | 116.11 Million INR | -62.14% |
| 2009 | 306.72 Million INR | -20.73% |
| 2008 | 386.92 Million INR | 102.3% |
| 2007 | 191.26 Million INR | 461.76% |
| 2006 | 34.04 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 1.31 Billion INR | 0.0% |
| 2023 Q2 | 1.25 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.18 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 1.18 Billion INR | 14.93% |
| 2022 Q2 | 1.07 Billion INR | 0.0% |
| 2022 Q4 | 1.03 Billion INR | 0.0% |
| 2022 FY | 1.03 Billion INR | -16.85% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.29 Billion INR | 0.0% |
| 2021 FY | 1.23 Billion INR | 25.29% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 1.23 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 989.27 Million INR | 33.44% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 989.27 Million INR | 0.0% |
| 2020 Q2 | 859.88 Million INR | 0.0% |
| 2019 Q2 | 769.71 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 741.38 Million INR | -4.17% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 741.38 Million INR | 0.0% |
| 2018 Q2 | 671.5 Million INR | 0.0% |
| 2018 FY | 773.67 Million INR | 31.06% |
| 2018 Q4 | 773.67 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 FY | 590.33 Million INR | 19.75% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 370.53 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 590.33 Million INR | 0.0% |
| 2016 Q4 | 492.98 Million INR | 0.0% |
| 2016 FY | 492.98 Million INR | 27.48% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 490.07 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q4 | 386.72 Million INR | 0.0% |
| 2015 FY | 386.72 Million INR | 14.76% |
| 2014 FY | 337 Million INR | 3.6% |
| 2013 FY | 325.3 Million INR | 0.02% |
| 2012 FY | 325.23 Million INR | 156.47% |
| 2012 Q2 | 364.22 Million INR | 0.0% |
| 2012 Q4 | 325.23 Million INR | 0.0% |
| 2011 FY | 126.8 Million INR | 9.21% |
| 2010 FY | 116.11 Million INR | -62.14% |
| 2009 FY | 306.72 Million INR | -20.73% |
| 2008 FY | 386.92 Million INR | 102.3% |
| 2007 FY | 191.26 Million INR | 461.76% |
| 2006 FY | 34.04 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 92.793% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 98.792% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 82.231% |
| Granules India Limited | 13 Billion INR | 90.892% |
| Indoco Remedies Limited | 3.53 Billion INR | 66.451% |
| Achyut Healthcare Limited | 568 Thousand INR | -208433.979% |
| Ajanta Pharma Limited | 8.28 Billion INR | 85.701% |
| Alkem Laboratories Limited | 26.61 Billion INR | 95.549% |
| Alpa Laboratories Limited | 136.65 Million INR | -766.774% |
| Brooks Laboratories Limited | 96.1 Million INR | -1132.44% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 48.023% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 17.767% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.136% |
| Eris Lifesciences Limited | 1.89 Billion INR | 37.34% |
| FDC Limited | 3.88 Billion INR | 69.542% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 95.287% |
| Gufic Biosciences Limited | 2 Billion INR | 40.919% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -1032.632% |
| Ipca Laboratories Limited | 24.71 Billion INR | 95.207% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -689.807% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1109.09% |
| Lasa Supergenerics Limited | 190.43 Million INR | -521.986% |
| Laurus Labs Limited | 18.45 Billion INR | 93.582% |
| Lupin Limited | 49.53 Billion INR | 97.609% |
| Mankind Pharma Limited | 15.53 Billion INR | 92.375% |
| Medicamen Biotech Limited | 593.75 Million INR | -99.49% |
| Medico Remedies Limited | 163.37 Million INR | -625.016% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 83.091% |
| Piramal Pharma Limited | 21.75 Billion INR | 94.556% |
| RPG Life Sciences Limited | 1.01 Billion INR | -17.275% |
| Sigachi Industries Limited | 707.2 Million INR | -67.486% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 98.8% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 48.768% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -461.854% |
| Unichem Laboratories Limited | 7.04 Billion INR | 83.191% |
| Wanbury Limited | 360.23 Million INR | -228.808% |
| Windlas Biotech Limited | 621.89 Million INR | -90.463% |
| ZIM Laboratories Limited | 812.62 Million INR | -45.758% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 96.559% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 96.28% |
| Hester Biosciences Limited | 755.81 Million INR | -56.716% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -8.558% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -309.786% |
| Bal Pharma Limited | 878.11 Million INR | -34.888% |
| Strides Pharma Science Limited | 11.26 Billion INR | 89.483% |
| Venus Remedies Limited | 1.21 Billion INR | 2.665% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 81.575% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 83.297% |
| Shilpa Medicare Limited | 3.44 Billion INR | 65.66% |
| Aarti Drugs Limited | 4.85 Billion INR | 75.623% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 72.12% |
| Suven Life Sciences Limited | 7.08 Million INR | -16618.038% |
| Ind-Swift Limited | 640.91 Million INR | -84.81% |
| Valiant Laboratories Limited | 100.15 Million INR | -1082.652% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 76.429% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 67.071% |
| Themis Medicare Limited | 705.74 Million INR | -67.833% |
| Hikal Limited | 3.03 Billion INR | 61.001% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 94.803% |
| Sequent Scientific Limited | 3.46 Billion INR | 65.79% |
| Novartis India Limited | 448.6 Million INR | -164.038% |
| Wockhardt Limited | 6.4 Billion INR | 81.493% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 90.815% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -4545.539% |
| Neuland Laboratories Limited | 3.5 Billion INR | 66.199% |
| Morepen Laboratories Limited | 2.48 Billion INR | 52.353% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -2870.093% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 4.2% |